Rudy Schreiber, PhD is with the Department of Neuropsychology & Psychopharmacology at Maastricht University. He is a neuroscientist and has worked in CNS drug discovery at a handful of companies, including Roche and Bayer. Rudy is coordinator of the research master specialization “drug development and neurohealth” and has a wide range of neuro-research interests. Keywords: cognition, serotonin, psychiatric disorders